Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.
- DOI
- 10.1136/jitc-2024-008857
- Published
- 2024 Apr 16
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2024-008857,
title = {Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.},
author = {Liu W and Liu W and Zou H and Chen L and Huang W and Lv R and Xu Y and Liu H and Shi Y and Wang K and Wang Y and Xiong W and Deng S and Yi S and Sui W and Peng G and Ma Y and Wang H and Lv L and Wang J and Wei J and Qiu L and Zheng W and Zou D},
year = {2024},
journal = {Journal for immunotherapy of cancer},
doi = {10.1136/jitc-2024-008857},
url = {https://doi.org/10.1136/jitc-2024-008857}
}RIS
TY - JOUR TI - Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma. AU - Liu W AU - Liu W AU - Zou H AU - Chen L AU - Huang W AU - Lv R AU - Xu Y AU - Liu H AU - Shi Y AU - Wang K AU - Wang Y AU - Xiong W AU - Deng S AU - Yi S AU - Sui W AU - Peng G AU - Ma Y AU - Wang H AU - Lv L AU - Wang J AU - Wei J AU - Qiu L AU - Zheng W AU - Zou D PY - 2024 JO - Journal for immunotherapy of cancer DO - 10.1136/jitc-2024-008857 UR - https://doi.org/10.1136/jitc-2024-008857 ER -
APA
W, L., W, L., H, Z., L, C., W, H., R, L., Y, X., H, L., Y, S., K, W., Y, W., W, X., S, D., S, Y., W, S., G, P., Y, M., H, W., L, L., J, W., J, W., L, Q., W, Z., & D, Z. (2024). Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2024-008857
Source records
- pubmed · retrieved 2026-09-26T21:02:34.842Z